Quantitative determination of the detection biomarkers of prostate cancer

摘要

The present invention is subject cancer, specifically to provide useful biomarkers for identifying whether a prostate cancer. Specifically, for diagnosing an individual with prostate cancer, individuals at risk of developing prostate cancer and / or for determining the prognosis of a subject with prostate cancer, betaine, malate, proline, N- acetyl aspartate, uracil, xanthine, cysteine, alanine, and N- acetyl glucosamine can be used. The present invention also relates to multiplexed assay to quantify such biomarkers. .BACKGROUND 23